4//SEC Filing
Dickason David 4
Accession 0001493152-20-019013
CIK 0000849636other
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 3:20 PM ET
Size
5.5 KB
Accession
0001493152-20-019013
Insider Transaction Report
Form 4
Dickason David
SVP of Pre-Clinical Prod. Dev.
Transactions
- Award
Common Stock Options (to purchase shares of Common Stock)
2020-09-30+2,000,000→ 2,000,000 totalExercise: $0.01Exp: 2025-09-30→ Common Stock (2,000,000 underlying)
Footnotes (1)
- [F1]These Common Stock Options vest in four equal installments: 25 percent on December 31, 2020, 25 percent on March 31, 2021, 25 percent on June 30, 2021, and 25 percent on September 30, 2021.
Documents
Issuer
RespireRx Pharmaceuticals Inc.
CIK 0000849636
Entity typeother
Related Parties
1- filerCIK 0001827349
Filing Metadata
- Form type
- 4
- Filed
- Oct 5, 8:00 PM ET
- Accepted
- Oct 6, 3:20 PM ET
- Size
- 5.5 KB